Molina Healthcare (MOH) – Investment Analysts’ Recent Ratings Updates

Molina Healthcare (NYSE: MOH) has recently received a number of price target changes and ratings updates:

• 7/14/2026 – Molina Healthcare was given a new $230.00 price target by Jefferies Financial Group Inc..
• 7/14/2026 – Molina Healthcare had its price target raised by TD Cowen from $163.00 to $230.00. They now have a “hold” rating on the stock.
• 7/14/2026 – Molina Healthcare had its price target raised by Truist Financial Corporation from $205.00 to $250.00. They now have a “hold” rating on the stock.
• 7/13/2026 – Molina Healthcare had its price target raised by Wells Fargo & Company from $159.00 to $235.00. They now have an “equal weight” rating on the stock.
• 7/13/2026 – Molina Healthcare was given a new $286.00 price target by Sanford C. Bernstein.
• 7/9/2026 – Molina Healthcare had its price target raised by Royal Bank Of Canada from $216.00 to $248.00. They now have a “sector perform” rating on the stock.
• 7/8/2026 – Molina Healthcare had its price target lowered by Barclays PLC from $199.00 to $184.00. They now have an “underweight” rating on the stock.
• 6/25/2026 – Molina Healthcare was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 6/23/2026 – Molina Healthcare is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $216.00 price target on the stock.
• 6/23/2026 – Molina Healthcare is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $216.00 price target on the stock.
• 6/8/2026 – Molina Healthcare was given a new $215.00 price target by Mizuho.
• 6/8/2026 – Molina Healthcare had its price target raised by JPMorgan Chase & Co. from $169.00 to $191.00. They now have a “neutral” rating on the stock.
• 6/4/2026 – Molina Healthcare had its price target raised by Morgan Stanley from $146.00 to $167.00. They now have an “equal weight” rating on the stock.
• 5/26/2026 – Molina Healthcare had its price target raised by Barclays PLC from $161.00 to $199.00. They now have an “underweight” rating on the stock.
• 5/22/2026 – Molina Healthcare had its price target raised by UBS Group AG from $180.00 to $202.00. They now have a “neutral” rating on the stock.

Insider Transactions at Molina Healthcare

In related news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 1.44% of the company’s stock.

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.